Page last updated: 2024-12-08

proglycosyn

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

proglycosyn: structure given in first source; proglycosyn is short for promotes glycogen synthesis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID147052
CHEMBL ID75285
SCHEMBL ID3853584
MeSH IDM0169093

Synonyms (12)

Synonym
CHEMBL75285
proglycosyn
103793-22-2
1h-imidazolium, 1-(2-(3-methoxyphenyl)-2-oxoethyl)-3-methyl-, bromide
ly-177507
1-methyl-3-(2-oxo-2-(3-methoxyphenyl)ethyl)-1h-imidazolium
1-methyl-3 (2-oxo-2-(3-methoxyphenyl)ethyl)-1h-imidazolium bromide
SCHEMBL3853584
1-(3-methoxyphenyl)-2-(3-methylimidazol-3-ium-1-yl)ethanone;bromide
1-[2-(3-methoxyphenyl)-2-oxoethyl]-3-methyl-1h-imidazol-3-ium bromide
DTXSID60908598
AKOS040753614
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID128906Percent blood glucose level in mice 2 hours after peroral administration of compound (100 mg/kg)1989Journal of medicinal chemistry, Oct, Volume: 32, Issue:10
Oral hypoglycemic agents. Discovery and structure-activity relationships of phenacylimidazolium halides.
AID128907Percent blood glucose level in mice 4 hours after peroral administration of compound (100 mg/kg)1989Journal of medicinal chemistry, Oct, Volume: 32, Issue:10
Oral hypoglycemic agents. Discovery and structure-activity relationships of phenacylimidazolium halides.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's8 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.10 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index25.55 (26.88)
Search Engine Supply Index3.14 (0.95)

This Compound (28.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]